Company Recognized with A- Score for its Ongoing Efforts SOUTHBOROUGH, Mass., Jan. 26, 2022 (GLOBE NEWSWIRE) — In recognition of its continuing actions to combat climate change, Virtusa Corporation received an A- score for its climate change response from the Carbon Disclosure Project (CDP), placing the company in the overall Leadership band. Virtusa was among the top […]

Read More

Featured Image for T-REX NEW YORK & TEL AVIV, Israel, Jan. 26, 2022 (GLOBE NEWSWIRE) — T-REX Group, Inc. (“T-REX”), a SaaS provider supporting the asset-backed financing industry, has announced a $40 million Series C funding round today, led by Riverstone Holdings LLC and Riverstone affiliates (“Riverstone”), with participation from existing shareholders Citi (NYSE: C), […]

Read More

Unstoppable NEW YORK, Jan. 26, 2022 (GLOBE NEWSWIRE) — After reaching number one, bestseller status on Amazon, Joshua M. Greene’s Unstoppable: Siggi B. Wilzig’s Astonishing Journey from Auschwitz Survivor and Penniless Immigrant to Wall Street Legend ends the year with another prestigious designation – “Business Book of the Year” from the well-respected and award-winning publication […]

Read More

The company scored above the overall average, with highest scores in the equal pay and gender pay parity categories This performance is a testament to Schneider Electric’s commitment to gender equality Rueil-Malmaison (France), January 26, 2022 – Schneider Electric, the global leader in the digital transformation of energy management and automation, today announced its inclusion […]

Read More

January 26, 2022 Philips expands remote cardiac monitoring portfolio with patch-based, clinical-grade ECG designed to improve patient recruitment, compliance and retention by reducing need for site visits during clinical trials Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the introduction of the industry’s first full-service, […]

Read More

GHENT, Belgium, Jan. 26, 2022 (GLOBE NEWSWIRE) — MRM Health, a clinical-stage biopharmaceutical company developing next-generation live microbiome consortia therapeutics, announced that it will present scientific data from its portfolio at the 6th Microbiome Movement Drug Development Europe Summit, resulting from its proprietary and unique CORAL™ platform technology. CEO Sam Possemiers will present MRM Health’s […]

Read More